Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial

被引：0
|
作者：
Catherine C. Going
Ludmila Alexandrova
Kenneth Lau
Christine Y. Yeh
David Feldman
Sharon J. Pitteri
机构：
[1] Stanford University School of Medicine,Department of Radiology, Canary Center at Stanford for Cancer Early Detection
[2] Stanford University,Vincent Coates Foundation Mass Spectrometry Laboratory
[3] Stanford University School of Medicine,Department of Biomedical Informatics
[4] Stanford University School of Medicine,Department of Medicine – Endocrinology
[5] Stanford University School of Medicine,Stanford Cancer Institute
来源：
Breast Cancer Research and Treatment | 2018年 / 167卷
关键词：
Vitamin D; Calcitriol; 27-hydroxycholesterol; ER+ breast cancer; CYP27A1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：797 / 802
页数：5
相关论文
共 50 条
  • [11] The cholesterol metabolite, 27-hydroxycholesterol, promotes breast cancer metastasis
    Nelson, Erik Russell
    Wardell, Suzanne E.
    McDonnell, Donald P.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [12] 27-hydroxycholesterol: A novel player in molecular carcinogenesis of breast and prostate cancer
    Marwarha, Gurdeep
    Raza, Shaneabbas
    Hammer, Kimberly
    Ghribi, Othman
    CHEMISTRY AND PHYSICS OF LIPIDS, 2017, 207 : 108 - 126
  • [13] Obesity and Cancer: 27-Hydroxycholesterol, the Missing Link
    Asghari, Arvand
    Umetani, Michihisa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (14) : 1 - 16
  • [14] Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer
    Kimbung, Siker
    Chang, Ching-yi
    Bendahl, Par-Ola
    Dubois, Laura
    Thompson, J. Will
    McDonnell, Donald P.
    Borgquist, Signe
    ENDOCRINE-RELATED CANCER, 2017, 24 (07) : 339 - 349
  • [15] 27-Hydroxycholesterol, The Estrogen Receptor Modulator, Alters DNA Methylation in Breast Cancer
    Vini, Ravindran
    Rajavelu, Arumugam
    Sreeharshan, Sreeja
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [16] The cholesterol metabolite 27-hydroxycholesterol increases breast cancer tumor growth and metastasis
    Nelson, Erik Russell
    Wardell, Suzanne E.
    Howe, Matthew K.
    Carver, Nicole J.
    Umetani, Michihisa
    McDonnell, Donald P.
    CANCER RESEARCH, 2013, 73
  • [17] Urolithin A: A promising selective estrogen receptor modulator and 27-hydroxycholesterol attenuator in breast cancer
    Vini, Ravindran
    Jaikumar, Vishnu Sunil
    Remadevi, Viji
    Ravindran, Swathy
    Azeez, Juberiya M.
    Sasikumar, Anjana
    Sundaram, Shankar
    Sreeja, Sreeharshan
    PHYTOTHERAPY RESEARCH, 2023, 37 (10) : 4504 - 4521
  • [18] Investigation of 27-hydroxycholesterol as a biomarker for aggressive endometrial cancer
    Sarink, Danja
    Loo, Lenora W.
    Killeen, Jeffrey
    Hernandez, Brenda Y.
    Chan, Owen T.
    Merrit, Melissa A.
    CANCER RESEARCH, 2020, 80 (16)
  • [19] The cholesterol metabolite 27-hydroxycholesterol promotes breast cancer progression by affecting immune responses
    Baek, Amy E.
    He, Sisi
    McDowell, Hannah B.
    Nelson, Erik R.
    CANCER RESEARCH, 2018, 78 (13)
  • [20] Circulating 27-hydroxycholesterol is associated with decreased breast cancer risk: The Multiethnic Cohort Study
    DeRouen, Mindy C.
    Yang, Juan
    Li, Yuqing
    Franke, Adrian A.
    Tome, Anne
    White, Kami
    Hernandez, Brenda
    Shvestov, Yurii
    Setiawan, V. Wendy
    Wu, Anna H.
    Wilkens, Lynne
    Le Marchand, Loic
    Loo, Lenora Wm
    Cheng, Iona
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
12345